Skip to contentC
CV Sciences, Inc.
C
CVSICV Sciences, Inc. Q4 2017 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$7.24M$7.24Mderived+125.6% vs Q4 2016 Net Income$469.95K$469.95KderivedN/M vs Q4 2016 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CV Sciences, Inc. · CIK 1510964 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$5,213,890+186.7% Operating Incomederived$135,277N/M Operating Cash Flowderived$2,967,784N/M Free Cash Flowderived$2,520,194N/M Margins · derivedGross margin72.0%+15.3 pt vs Q4 2016
Operating margin1.9%+258.1 pt vs Q4 2016
Net margin6.5%+270.7 pt vs Q4 2016
ended Dec 31, 2017 · filed Mar 30, 2018 · 89 d after period end